Диссертация (Экспрессия генов транскрипционных факторов LXRalpha, LXRbeta, PPARgamma и транспортера ABCA1 при атеросклерозе), страница 18

1997. Т. 7. № 7. — C. 256-63.159. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABCtransporters, and cholesterol efflux: implications for the treatment of atherosclerosis //Cell Metab. 2008. Т. 7. № 5. — C. 365-75.160. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R.,Laffitte B.A., Daige C.L., Thomas D., Heyman R.A., Mangelsdorf D.J., Wang X., LusisA.J., Tontonoz P., Schulman I.G. Identification of macrophage liver X receptors asinhibitors of atherosclerosis // Proc Natl Acad Sci U S A.

2002. Т. 99. № 18. — C. 11896901.161. Teupser D., Kretzschmar D., Tennert C., Burkhardt R., Wilfert W., FenglerD., Naumann R., Sippel A.E., Thiery J. Effect of macrophage overexpression of murineliver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice //Arterioscler Thromb Vasc Biol. 2008. Т. 28. № 11.

— C. 2009-15.162. Thymiakou E., Zannis V.I., Kardassis D. Physical and functional interactionsbetween liver X receptor/retinoid X receptor and Sp1 modulate the transcriptionalinduction of the human ATP binding cassette transporter A1 gene by oxysterols andretinoids // Biochemistry. 2007. Т. 46. № 41. — C. 11473-83.163.

Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M.PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidizedLDL // Cell. 1998. Т. 93. № 2. — C. 241-52.164. Toth P.P. Should we target HDL cholesterol level in lowering cardiovascularrisk? // Pol Arch Med Wewn. 2009. Т. 119. № 10. — C. 667-72.165. Valledor A.F., Ricote M. Nuclear receptor signaling in macrophages //Biochem Pharmacol.

2004. Т. 67. № 2. — C. 201-12.166. Van Dam M.J., de Groot E., Clee S.M., Hovingh G.K., Roelants R., BrooksWilson A., Zwinderman A.H., Smit A.J., Smelt A.H., Groen A.K., Hayden M.R.,113Kastelein J.J. Association between increased arterial-wall thickness and impairment inABCA1-driven cholesterol efflux: an observational study // Lancet. 2002. Т.

359. №9300. — C. 37-42.167. Van Eck M., Bos I.S., Kaminski W.E., Orso E., Rothe G., Twisk J., BottcherA., Van Amersfoort E.S., Christiansen-Weber T.A., Fung-Leung W.P., Van Berkel T.J.,Schmitz G. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophagerecruitment into tissues // Proc Natl Acad Sci U S A. 2002.

Т. 99. № 9. — C. 6298-303.168. Van Eck M., Singaraja R.R., Ye D., Hildebrand R.B., James E.R., HaydenM.R., Van Berkel T.J. Macrophage ATP-binding cassette transporter A1 overexpressioninhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockoutmice // Arterioscler Thromb Vasc Biol.

2006. Т. 26. № 4. — C. 929-34.169. Voloshyna I., Reiss A.B. The ABC transporters in lipid flux andatherosclerosis // Prog Lipid Res. 2011. Т. 50. № 3. — C. 213-24.170. Wahli W., Michalik L. PPARs at the crossroads of lipid signaling andinflammation // Trends Endocrinol Metab. 2012. Т. 23. № 7. — C. 351-63.171. Waldo S.W., Li Y., Buono C., Zhao B., Billings E.M., Chang J., Kruth H.S.Heterogeneity of Human Macrophages in Culture and in Atherosclerotic Plaques //American Journal of Pathology.

2008. Т.172. — С.1112 – 1126.172. Wang M.D., Franklin V., Marcel Y.L. In vivo reverse cholesterol transportfrom macrophages lacking ABCA1 expression is impaired // Arterioscler Thromb VascBiol. 2007. Т. 27. № 8. — C. 1837-42 - a.173. Wang N., Chen W., Linsel-Nitschke P., Martinez L.O., Agerholm-Larsen B.,Silver D.L., Tall A.R. A PEST sequence in ABCA1 regulates degradation by calpainprotease and stabilization of ABCA1 by apoA-I // J Clin Invest. 2003. Т. 111.

№ 1. — C.99-107.174. Wang N., Lan D., Chen W., Matsuura F., Tall A.R. ATP-binding cassettetransporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins //Proc Natl Acad Sci U S A. 2004. Т. 101. № 26. — C. 9774-9.114175. Wang N., Silver D.L., Costet P., Tall A.R.

Specific binding of ApoA-I,enhanced cholesterol efflux, and altered plasma membrane morphology in cellsexpressing ABC1 // J Biol Chem. 2000. Т. 275. № 42. — C. 33053-8.176. Wang Q.G., Guo Z.G., Lai W.Y., Zha Z., Liu Y.Y., Liu L. [Detection ofsingle nucleotide polymorphism of all coding regions in ABCA1 gene in patients withcoronary heart disease] // Nan Fang Yi Ke Da Xue Xue Bao.

2006. Т. 26. № 1. — C. 425.177. Wang X., Collins H.L., Ranalletta M., Fuki I.V., Billheimer J.T., RothblatG.H., Tall A.R., Rader D.J. Macrophage ABCA1 and ABCG1, but not SR-BI, promotemacrophage reverse cholesterol transport in vivo // J Clin Invest. 2007. Т. 117. № 8. —C. 2216-24 - b.178. Wang Y., Kurdi-Haidar B., Oram J.F. LXR-mediated activation ofmacrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilizeABCA1 // J Lipid Res. 2004. Т.

45. № 5. — C. 972-80.179. Wellington C.L., Walker E.K., Suarez A., Kwok A., Bissada N., SingarajaR., Yang Y.Z., Zhang L.H., James E., Wilson J.E., Francone O., McManus B.M., HaydenM.R. ABCA1 mRNA and protein distribution patterns predict multiple different roles andlevels of regulation // Lab Invest. 2002. Т. 82. № 3. — C. 273-83.180. Wilson P.W., Castelli W.P., Kannel W.B. Coronary risk prediction in adults(the Framingham Heart Study) // Am J Cardiol. 1987. Т.

59. № 14. — C. 91G-94G.181. Wong J., Quinn C.M., Gelissen I.C., Jessup W., Brown A.J. The effect ofstatins on ABCA1 and ABCG1 expression in human macrophages is influenced bycellular cholesterol levels and extent of differentiation // Atherosclerosis. 2008. Т. 196.№ 1. — C. 180-9.182.

Wu Z., Lou Y., Jin W., Liu Y., Lu L., Lu G. The Pro12Ala polymorphism inthe peroxisome proliferator-activated receptor gamma-2 gene (PPARgamma2) isassociated with increased risk of coronary artery disease: a meta-analysis // PLoS One.2012. Т. 7. № 12. — C. e53105.183. Yang H., Mohamed A.S., Zhou S.H. Oxidized low density lipoprotein, stemcells, and atherosclerosis // Lipids Health Dis. 2012. Т.

11. — C. 85.115184. Yessoufou A., Wahli W. Multifaceted roles of peroxisome proliferatoractivated receptors (PPARs) at the cellular and whole organism levels // Swiss Med Wkly.2010. Т. 140. — C. w13071.185. Yin Y.W., Li J.C., Gao D., Chen Y.X., Li B.H., Wang J.Z., Liu Y., LiaoS.Q., Zhang M.J., Gao C.Y., Zhang L.L. Influence of ATP-binding cassette transporter 1R219K and M883I polymorphisms on development of atherosclerosis: a meta-analysis of58 studies // PLoS One.

2014. Т. 9. № 1. — C. e86480.186. Yu X., Murao K., Imachi H., Li J., Nishiuchi T., Hosomi N., Masugata H.,Zhang G.X., Iwama H., Ishida T. Hyperglycemia suppresses ABCA1 expression invascular smooth muscle cells // Horm Metab Res. 2010. Т. 42. № 4. — C. 241-6.187. Yvan-Charvet L., Ranalletta M., Wang N., Han S., Terasaka N., Li R., WelchC., Tall A.R. Combined deficiency of ABCA1 and ABCG1 promotes foam cellaccumulation and accelerates atherosclerosis in mice // J Clin Invest. 2007. Т.

117. № 12.— C. 3900-8.188. Yvan-Charvet L., Wang N., Tall A.R. Role of HDL, ABCA1, and ABCG1transporters in cholesterol efflux and immune responses // Arterioscler Thromb VascBiol. 2010. Т. 30. № 2. — C. 139-43.189. Yvan-Charvet L., Welch C., Pagler T.A., Ranalletta M., Lamkanfi M., HanS., Ishibashi M., Li R., Wang N., Tall A.R. Increased inflammatory gene expression inABC transporter-deficient macrophages: free cholesterol accumulation, increasedsignaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions //Circulation.

2008. Т. 118. № 18. — C. 1837-47.190. Zanotti I., Pedrelli M., Poti F., Stomeo G., Gomaraschi M., Calabresi L.,Bernini F. Macrophage, but not systemic, apolipoprotein E is necessary for macrophagereverse cholesterol transport in vivo // Arterioscler Thromb Vasc Biol. 2011. Т. 31. № 1.— C.

74-80.191. Zhang Y., Zanotti I., Reilly M.P., Glick J.M., Rothblat G.H., Rader D.J.Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol frommacrophages to feces in vivo // Circulation. 2003. Т. 108. № 6. — C. 661-3.116192. Zhao C., Dahlman-Wright K. Liver X receptor in cholesterol metabolism //J Endocrinol. 2010. Т. 204. № 3. — C. 233-40.193. Zhou X., Yin Z., Guo X., Hajjar D.P., Han J. Inhibition of ERK1/2 andactivation of liver X receptor synergistically induce macrophage ABCA1 expression andcholesterol efflux // J Biol Chem. 2010.

Т. 285. № 9. — C. 6316-26.194. Zhu X., Lee J.Y., Timmins J.M., Brown J.M., Boudyguina E., Mulya A.,Gebre A.K., Willingham M.C., Hiltbold E.M., Mishra N., Maeda N., Parks J.S. Increasedcellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances proinflammatory response of macrophages // J Biol Chem. 2008. Т. 283. № 34. — C. 2293041.195. Zwarts K.Y., Clee S.M., Zwinderman A.H., Engert J.C., Singaraja R.,Loubser O., James E., Roomp K., Hudson T.J., Jukema J.W., Kastelein J.J., Hayden M.R.ABCA1 regulatory variants influence coronary artery disease independent of effects onplasma lipid levels // Clin Genet. 2002. Т. 61.

№ 2. — C. 115-25..